Confluent (NASDAQ:CFLT) and Oncology Pharma (OTCMKTS:ONPH) Head-To-Head Comparison

Confluent (NASDAQ:CFLT) and Oncology Pharma (OTCMKTS:ONPH) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.

Profitability

This table compares Confluent and Oncology Pharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Confluent	-42.70%	-38.46%	-12.95%
Oncology Pharma	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for Confluent and Oncology Pharma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Confluent	1	6	22	0	2.72
Oncology Pharma	0	0	0	0	N/A

Confluent currently has a consensus target price of $31.04, indicating a potential upside of 60.93%.

Volatility & Risk

Confluent has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500. Comparatively, Oncology Pharma has a beta of -1.04, indicating that its stock price is 204% less volatile than the S&P 500.

Institutional & Insider Ownership

78.1% of Confluent shares are owned by institutional investors. 13.8% of Confluent shares are owned by company insiders. Comparatively, 18.0% of Oncology Pharma shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Confluent and Oncology Pharma’s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Confluent	$776.95 million	7.89	-$442.75 million	($1.25)	-15.43
Oncology Pharma	N/A	N/A	N/A	N/A	N/A

Oncology Pharma has lower revenue, but higher earnings than Confluent.

About Confluent

Confluent, Inc. operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software. It offers connectors for existing applications, and IT and cloud infrastructure; Apache Flink services that allows teams to create reusable data streams that can be delivered real-time; ksqlDB, a data-in-motion database that allows users to build data-in-motion applications using a few SQL statements; stream governance, a managed data governance suite that is designed for the intricacies of streaming data, which allows teams to accelerate data streaming initiatives without bypassing controls for risk management and regulatory compliance; and stream designer which builds streaming data pipelines visually. In addition, the company offers professional services comprising packaged and residency offerings; education offerings consisting of instructor-led and self-paced training and certification guidance, technical resources, and access to hands-on training and certification exams; and certification programs. It serves banking and financial services industries, as well as retail and e-commerce, manufacturing, automotive, communication service providers, gaming, public sector, insurance, and technology industries. The company was formerly known as Infinitem, Inc. and changed its name to Confluent, Inc. in September 2014. Confluent, Inc. was incorporated in 2014 and is headquartered in Mountain View, California.

About Oncology Pharma

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.